This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Biola, A. Articles by Pallardy, M. Search for Related Content PubMed PubMed Citation Articles by Biola, A. Articles by Pallardy, M.

Interleukin-2 Inhibits Glucocorticoid Receptor Transcriptional Activity through a Mechanism Involving STAT5 (Signal Transducer and Activator of Transcription 5) but Not AP-1

INSERM U461 (A.B., M.S., J.B., M.P., M.P.-W.) Faculté de Pharmacie Paris-Sud 92296 Châtenay-Malabry, France
INSERM U459 (P.L.) Faculté de Médecine Henri Warembourg 59045 Lille, France

Cytokines and glucocorticoids (GCs) signaling pathways interfere with each other in the regulation of apoptosis and gene expression in the immune system. Interleukin-2 (IL-2), through the Janus kinase/signal transducers and activators of transcription (Jak/STAT) and mitogen-activated protein kinase (MAPK) pathways, activates STAT5 and activated protein-1 (AP-1) transcription factors, respectively, which are known to repress glucocorticoid receptor (GR) activity, at least in part, through protein-protein interactions. In this work, we have analyzed the mechanisms whereby IL-2 down-regulates the GC-induced transactivation of the mouse mammary tumor virus long terminal repeat (MMTV-LTR) in murine CTLL-2 T lymphocytes. Mutagenesis studies revealed that the MMTV-LTR STAT5 binding site (-923/-914) was not required for IL-2-mediated inhibition but identified both glucocorticoid response elements (GREs) and the -104/+1 region as critical elements for this negative response. The DNA binding activities of transcription factors required for GC-mediated activation of the MMTV-LTR promoter and that bind to the -104/+1 region (nuclear factor-1, Oct-1) were not affected by IL-2 treatment. Overexpression of wild-type STAT5B enhanced the effect of IL-2 on MMTV-LTR activity, and a dominant negative form of STAT5B (Y699F) abolished the IL-2-mediated MMTV-LTR inhibition, whereas AP-1 activation had no effect in this system. Direct interaction between liganded GR and STAT5 was observed in CTLL-2 cells in a STAT5 phosphorylation-independent manner. Overexpression of nuclear coactivators CBP (CREB-binding protein) or SRC-1a (steroid receptor coactivator 1a) did not blunt IL-2 inhibitory effects. We suggest that the STAT5-repressive activity on the GC-dependent transcription may involve direct interaction of STAT5 with GR, is dependent on the promoter context and STAT5 activation level, and occurs independently of coactivators levels in T cells.

This article has been cited by other articles:

				A. M. Mikheev, T. Nabekura, A. Kaddoumi, T. K. Bammler, R. Govindarajan, M. F. Hebert, and J. D. Unadkat Profiling Gene Expression in Human Placentae of Different Gestational Ages: An OPRU* Network and UW SCOR Study Reproductive Sciences, November 1, 2008; 15(9): 866 - 877. [Abstract] [PDF]

				J. E Morabito, J. F Trott, D. M Korz, H. E Fairfield, S. H Buck, and R. C Hovey A 5' distal palindrome within the mouse mammary tumor virus-long terminal repeat recruits a mammary gland-specific complex and is required for a synergistic response to progesterone plus prolactin J. Mol. Endocrinol., August 1, 2008; 41(2): 75 - 90. [Abstract] [Full Text] [PDF]

				D. Engblom, J.-W. Kornfeld, L. Schwake, F. Tronche, A. Reimann, H. Beug, L. Hennighausen, R. Moriggl, and G. Schutz Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression Genes & Dev., May 15, 2007; 21(10): 1157 - 1162. [Abstract] [Full Text] [PDF]

				A. McMaster and D. W. Ray Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects Exp Physiol, March 1, 2007; 92(2): 299 - 309. [Abstract] [Full Text] [PDF]

				L. Rocha-Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci Glucocorticoids Repress bcl-X Expression in Lymphoid Cells by Recruiting STAT5B to the P4 Promoter J. Biol. Chem., November 10, 2006; 281(45): 33959 - 33970. [Abstract] [Full Text] [PDF]

				M. Shi, J. C. Cooper, and C.-L. Yu A Constitutively Active Lck Kinase Promotes Cell Proliferation and Resistance to Apoptosis through Signal Transducer and Activator of Transcription 5b Activation Mol. Cancer Res., January 1, 2006; 4(1): 39 - 45. [Abstract] [Full Text] [PDF]

				A. Kariagina, S. Zonis, M. Afkhami, D. Romanenko, and V. Chesnokova Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E857 - E863. [Abstract] [Full Text] [PDF]

				M.-L. Asselin-Labat, A. Biola-Vidamment, S. Kerbrat, M. Lombes, J. Bertoglio, and M. Pallardy FoxO3 Mediates Antagonistic Effects of Glucocorticoids and Interleukin-2 on Glucocorticoid-Induced Leucine Zipper Expression Mol. Endocrinol., July 1, 2005; 19(7): 1752 - 1764. [Abstract] [Full Text] [PDF]

				S. A. Perez, L. G. Mahaira, F. J. Demirtzoglou, P. A. Sotiropoulou, P. Ioannidis, E. G. Iliopoulou, A. D. Gritzapis, N. N. Sotiriadou, C. N. Baxevanis, and M. Papamichail A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival Blood, July 1, 2005; 106(1): 158 - 166. [Abstract] [Full Text] [PDF]

				B. M. Necela and J. A. Cidlowski Mechanisms of Glucocorticoid Receptor Action in Noninflammatory and Inflammatory Cells Proceedings of the ATS, November 1, 2004; 1(3): 239 - 246. [Full Text] [PDF]

				M.-L. Asselin-Labat, M. David, A. Biola-Vidamment, D. Lecoeuche, M.-C. Zennaro, J. Bertoglio, and M. Pallardy GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis Blood, July 1, 2004; 104(1): 215 - 223. [Abstract] [Full Text] [PDF]

				J. L. Bromberg-White, E. Sen, S. Alam, J. M. Bodily, and C. Meyers Induction of the Upstream Regulatory Region of Human Papillomavirus Type 31 by Dexamethasone Is Differentiation Dependent J. Virol., October 15, 2003; 77(20): 10975 - 10983. [Abstract] [Full Text] [PDF]

				E. Goleva, K. O. Kisich, and D. Y. M. Leung A Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance J. Immunol., November 15, 2002; 169(10): 5934 - 5940. [Abstract] [Full Text] [PDF]